MD Anderson Team Reports Dual MYC-GSPT1 Degrader for Blood Cancers

Institution: MD Anderson (with Kintor, Oncobio, Columbia) · Event Type: Peer-Reviewed Publication (Blood) · Compound: GT19630 · Mechanism: Cereblon-Dependent Dual MYC/GSPT1 Degrader · Indications: AML, Burkitt Lymphoma, Multiple Myeloma · Publication Date: August 17, 2026 Summary A peer-reviewed Blood study reports GT19630, a cereblon-dependent small-molecule…